Elizabeth Hurlburt
CIK 1735256 · View on SEC EDGAR ↗
First SEC filing: Nov. 18, 2024 · Latest: Nov. 18, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | CRMD | S | 41,121 | $13.08 | $537,863 | 176,990 Direct | -18.85% | Disposed | -34.8% (price as of 2026-08-20) |
| Sept. 9, 2025 | CRMD | S | 12,876 | $13.51 | $173,955 | 176,990 Direct | -6.78% | Disposed | -36.9% (price as of 2026-08-20) |
| Nov. 14, 2024 | CRMD | S | 140,027 | $11.18 | $1,565,502 | 45,397 Direct | -75.52% | Disposed | -23.7% (price as of 2026-08-20) |
| May 21, 2021 | CRMD | S | 8,000 | $6.92 | $55,360 | 0 Direct | -100.00% | Disposed | 23.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (41,121) | $1.45 | March 19, 2028 | 41,121 | Disposed |
| Sept. 9, 2025 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (12,876) | $1.45 | March 19, 2028 | 12,876 | Disposed |
| Nov. 14, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (25,000) | $3.47 | Jan. 11, 2034 | 25,000 | Disposed |
| Nov. 14, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (62,500) | $4.43 | Jan. 14, 2033 | 62,500 | Disposed |
| Nov. 14, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (34,467) | $4.08 | May 11, 2030 | 34,467 | Disposed |
| Nov. 14, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (9,888) | $5.63 | May 11, 2030 | 9,888 | Disposed |
| Nov. 14, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (8,169) | $8.30 | Jan. 10, 2029 | 8,169 | Disposed |
| Nov. 14, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (3) | $1.45 | March 19, 2028 | 3 | Disposed |
| Jan. 12, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (100,000) | $3.47 | Jan. 11, 2034 | 100,000 | Acquired |
| Jan. 14, 2023 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (125,000) | $4.43 | Jan. 14, 2033 | 125,000 | Acquired |
| Feb. 18, 2022 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (100,000) | $4.03 | Feb. 18, 2032 | 100,000 | Acquired |
| Jan. 11, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (140,000) | $8.32 | Jan. 11, 2031 | 140,000 | Acquired |
| May 11, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (37,500) | $4.08 | May 11, 2030 | 37,500 | Acquired |
| May 11, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (37,500) | $5.63 | May 11, 2030 | 37,500 | Acquired |
| Feb. 25, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (24,764) | $5.63 | Feb. 25, 2030 | 24,764 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $479,640 | — | $2,784,318 | — | $420,527 | — | $59,203 | $3,743,688 |
| 2021 | $310,800 | $37,800 | — | $742,910 | — | — | $44,818 | $1,136,328 |
| 2020 | $291,792 | — | — | $332,420 | $136,500 | — | $35,561 | $796,273 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.